Yajing Zhu Selected Research

Breast Neoplasms (Breast Cancer)

1/2024	The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial.
1/2022	Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yajing Zhu Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2022
2	Cognitive Dysfunction 01/2023 - 12/2015
2	Neoplasms (Cancer) 02/2019 - 10/2011
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2019 - 06/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Olfaction Disorders (Cacosmia) 01/2024
1	Allergic Rhinitis 07/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Autism Spectrum Disorder 01/2023
1	Disease Progression 01/2023
1	Infections 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021
1	Heart Arrest (Cardiac Arrest) 12/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Schizophrenia (Dementia Praecox) 12/2015
1	Psychotic Disorders (Schizoaffective Disorder) 12/2015
1	Carcinogenesis 10/2011

Drug/Important Bio-Agent (IBA)

3	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2024
2	Glutamic Acid (Glutamate)FDA Link 01/2019 - 06/2015
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	thymidine kinase 1IBA 01/2024
1	ProstaglandinsIBA 07/2023
1	LeukotrienesIBA 07/2023
1	balovaptanIBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 02/2019
1	Gefitinib (Iressa)FDA Link 02/2019
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Choline (Choline Chloride)IBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 12/2015
1	Antipsychotic Agents (Antipsychotics)IBA 12/2015
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2015
1	Protons (Proton)IBA 06/2015
1	Cadherins (E-Cadherin)IBA 10/2011
1	Proteins (Proteins, Gene)FDA Link 10/2011
1	CateninsIBA 10/2011

Therapy/Procedure

1	Neoadjuvant Therapy 01/2022
1	Therapeutics 01/2021
1	Critical Care (Surgical Intensive Care) 12/2020
1	Patient Readmission 12/2020
1	CT protocol 01/2020
1	Long-Term Care 01/2019
1	Condoms (Condom) 01/2017